Business
IBN Announces Latest Episode of The BioMedWire Podcast Featuring Harry Simeonidis, President and CEO of Intelligent Bio Solutions Inc.
AUSTIN, Texas, June 17, 2025 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The BioMedWire Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The BioMedWire Podcast delivers dynamic interviews with industry experts at the forefront of pharmaceutical and biotech advanceme
About this update from Intelligent Bio Solutions Inc.
[{"type":"image","alt":"InvestorBrandNetwork (IBN)","displaySize":"","headline":null,"caption":"InvestorBrandNetwork (IBN)","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":169,"url":"https://media.zenfs.com/en/globenewswire.com/0a75ed90c9546495e45b8a96c60d10bd"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/fUCiYWRAsZ4cB0BZl4MQrQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIzNztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/0a75ed90c9546495e45b8a96c60d10bd","width":300,"height":169}},"lazy":false},{"type":"text","content":"AUSTIN, Texas, June 17, 2025 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The BioMedWire Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels.","length":370,"tagName":"p"},{"type":"text","content":"The BioMedWire Podcast delivers dynamic interviews with industry experts at the forefront of pharmaceutical and biotech advancement. The latest episode features Harry Simeonidis, CEO of Intelligent Bio Solutions Inc. (NASDAQ: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing solutions.","length":324,"tagName":"p"},{"type":"text","content":"During the interview, Simeonidis provided an overview of Intelligent Bio Solutions’ core offering and strategic direction.","length":122,"tagName":"p"},{"type":"text","content":"“We bring a unique technology to the drug screening market,” he explained. “We have a product that detects drugs from the sweat on the top of your fingertips. It’s a whole new way of doing drug screening for people who come to work every single day.”","length":250,"tagName":"p"},{"type":"text","content":"Simeonidis emphasized the company’s rapid expansion, noting early traction in the U.K. and current deployment across roughly 20 countries. “We’re a non-invasive technology company expanding globally with a lot of growth and revenue,” he said. “We’ve submitted our FDA application, and once we clear that, we expect to be in the U.S. in the second half of the year.”","length":365,"tagName":"p"},{"type":"text","content":"He described the fingerprint-based test as faster, simpler and more affordable than traditional methods. “You can s...